Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist medicine. To lower A1C, it enhances insulin synthesis (which lowers blood glucose) while inhibiting glucagon production (which raises blood glucose). One of the most significant benefits of Rybelsus medication is that it is the only licensed GLP-1 prescription that can be taken as a pill rather than an injection, making it more convenient.
Rybelsus 3 mg may also aid in the weight loss of patients with type 2 diabetes. This is due to the medication’s ability to suppress appetite and increase feelings of fullness, resulting in weight loss. This is especially essential for people with type 2 diabetes because decreasing weight is a key way to avoid complications.
Furthermore, scientific research has revealed that Rybelsus 7 mg tablet protects the heart. Participants in the Pioneer 6 trial who took Rybelsus 14 mg experienced cardiovascular protection. Because diabetics are more likely to develop heart disease, using a single medication that tackles both high blood sugar and heart health can be convenient.
